Tonsils - tonsillar neoplasms

	Tweet

Cancers of the tonsil tend to be superficial, better differentiated, and of an earlier stage than other oropharyngeal tumors. The treatment of early tonsillar neoplasms (stages I and II) is usually radiation therapy alone. Transoral wide local excision of small, superficial lesions may be locally effective, but does not address the high potential of occult lymph node metastasis. Deeply invasive cancers require extensive resections of the pharyngeal wall or mandible.

Radiation for early cancers offers the advantage of treating upper-echelon lymph nodes. Treatment is usually unilateral unless extension to the tongue base or midline soft palate is present that warrants treatment of contralateral lymphatics. Ipsilateral treatment portals allow sparing of the contralateral mucosa and salivary glands. Because much of the tumor may be hidden from external beam photons by the mandible, deeper dose calculation with electron beam therapy is used, which can be combined with a small interstitial implant if invasion of adjacent tongue is present. Early cancers of the tonsillar pillar are less effectively treated with radiation alone than are cancers confined to the tonsillar fossa.

Radical radiotherapy to lymph nodes controls approximately 90% of limited nodal disease (N1) if the primary tumor is controlled, but nodal failure increases to more than 20% if failure occurs at the primary tumor site. Overall 5-year survival rates for patients with advanced primary tumors or regional metastases are generally less than 25% with single-modality therapy. Combinations of surgery and radiation therapy offer improved rates of local and regional tumor control, which, in some studies, has translated into improved survival. Similar tumor-control and survival rates have been reported for stage III (T3N0) patients without nodal metastases who are treated with radiation alone or combined surgery and radiation or surgery alone (Table 90-9). In general, preoperative or postoperative radiation for advanced (stage III or IV) cancers of the tonsillar fossa is recommended, combined with resection to include the tonsillar fossa and regional nodes. In some instances, advances in surgical approaches may allow for sparing of the mandible, but composite resection of the pharynx, mandible, and neck remains a frequent surgical approach. Postoperative rather than preoperative radiation is currently preferred because it allows more accurate assessment of surgical margins, local extent of disease, and degree of lymphatic involvement, and is associated with lower rates of surgical complications.

RELATED STORIES:
Technologic Advances - Head and neck cancers Radiation Therapy   The Larynx - laryngeal cancers treatment   Oral Cavity   Head and neck cancer Diagnosis and Staging   Primary Chemotherapy - Head and neck cancer   The Hypopharynx - Hypopharyngeal cancers   Chemotherapy of Recurrent HNSCC - Head and neck cancer   Accelerated and Hyperfractionated Radiotherapy - treatment of head and neck cancer   The Neck   Head and neck cancers Radiation Therapy   Floor of Mouth cancers   Neoadjuvant Therapy - Head and neck cancer   Glottic and Subglottic Cancers treatment   Natural History and Treatment by site   Gingival and Buccal Mucosa cancers   Head and neck cancer Epidemiology   Curative Radiotherapy - Head and neck cancers Radiation Therapy   Head and neck cancer Adjuvant Chemotherapy   Head and neck cancer Anatomy   Retromolar Trigone cancers   Carcinoma in Situ   Head and neck cancer Pathologic Assessment

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]